Liu M - Search Results

1

Treatment strategy for myocarditis in patients using immune checkpoint inhibitors or combined anti-vascular endothelial growth factor therapy by clinical severity.

Liu Q, Yu Y, Lin J, Wang Y, Ai L, Li Q, Wu W, Jin H, Li S, Liu M, Yu S, Liu T. Liu Q, et al. Among authors: liu m, liu t. Eur J Cancer. 2021 Nov;157:10-20. doi: 10.1016/j.ejca.2021.07.023. Epub 2021 Aug 28. Eur J Cancer. 2021. PMID: 34464781

2

Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.

Chen EB, Wei YC, Liu HN, Tang C, Liu ML, Peng K, Liu T. Chen EB, et al. Biomed Res Int. 2019 Dec 13;2019:6710428. doi: 10.1155/2019/6710428. eCollection 2019. Biomed Res Int. 2019. PMID: 31915699 Free PMC article.

3

SLC25A18 has prognostic value in colorectal cancer and represses Warburg effect and cell proliferation via Wnt signaling.

Liang L, Chen Y, Yu Y, Pan W, Cui Y, Xu X, Peng K, Liu M, Rashid K, Hou Y, Liu T. Liang L, et al. Among authors: liu m, liu t. Am J Cancer Res. 2020 May 1;10(5):1548-1567. eCollection 2020. Am J Cancer Res. 2020. PMID: 32509397 Free PMC article.

4

Familial juvenile polyposis syndrome with a de novo germline missense variant in BMPR1A gene: a case report.

Liu Q, Liu M, Liu T, Yu Y. Liu Q, et al. Among authors: liu m, liu t. BMC Med Genet. 2020 Oct 8;21(1):196. doi: 10.1186/s12881-020-01135-6. BMC Med Genet. 2020. PMID: 33032550 Free PMC article.

5

Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.

Xu X, Yu Y, Shen M, Liu M, Wu S, Liang L, Huang F, Zhang C, Guo W, Liu T. Xu X, et al. Among authors: liu m, liu t. BMC Cancer. 2020 Oct 16;20(1):1006. doi: 10.1186/s12885-020-07516-7. BMC Cancer. 2020. PMID: 33066758 Free PMC article.

6

Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer.

Liang L, Liu M, Sun X, Yuan Y, Peng K, Rashid K, Yu Y, Cui Y, Chen Y, Liu T. Liang L, et al. Among authors: liu m, liu t. Cancer Cell Int. 2021 Feb 25;21(1):135. doi: 10.1186/s12935-021-01829-8. Cancer Cell Int. 2021. PMID: 33632198 Free PMC article.

7

Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation.

Rashid K, Ahmad A, Liang L, Liu M, Cui Y, Liu T. Rashid K, et al. Among authors: liu m, liu t. Drug Discov Today. 2021 Jul;26(7):1689-1701. doi: 10.1016/j.drudis.2021.03.004. Epub 2021 Mar 15. Drug Discov Today. 2021. PMID: 33737072 Review.

8

Identification of a metabolic signature to predict overall survival for colorectal cancer.

Yuan Y, Liu M, Hou P, Liang L, Sun X, Gan L, Liu T. Yuan Y, et al. Among authors: liu m, liu t. Scand J Gastroenterol. 2021 Sep;56(9):1078-1087. doi: 10.1080/00365521.2021.1948605. Epub 2021 Jul 14. Scand J Gastroenterol. 2021. PMID: 34261388

9

Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review.

Xu X, Yu Y, Liu M, Liang L, Liu T. Xu X, et al. Among authors: liu m, liu t. Transl Cancer Res. 2022 Jan;11(1):276-287. doi: 10.21037/tcr-20-3539. Transl Cancer Res. 2022. PMID: 35261903 Free PMC article. Review.

10

An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis.

Chen YJ, Hong WF, Liu ML, Guo X, Yu YY, Cui YH, Liu TS, Liang L. Chen YJ, et al. Cell Death Dis. 2022 Mar 14;13(3):237. doi: 10.1038/s41419-022-04692-1. Cell Death Dis. 2022. PMID: 35288533 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,464 results

Search Page

Filters